Clarivate's Highly Cited Researchers list became a market Saudi universities bought into — the exact misuse Garfield warned about

Core claims

1. Clarivate's "Highly Cited Researchers" (HCR) list became a purchasable credential. King Abdulaziz University (KAU) and King Saud University offered top-cited foreign scientists cash (reported figures include ~$72,000/year plus business-class travel and hotels) to add KAU as a secondary affiliation, requiring only brief annual visits. The count of HCR-listed researchers with a Saudi affiliation rose from 27 (2014) to 109 (2022), then fell back to 76 after Clarivate tightened affiliation-verification rules. — source_tier: 3 (Science/AAAS news reporting; the underlying HCR count changes are Clarivate's own published lists, not independently re-verified here — flag as [unverified-quant, secondary reporting of a primary count]).

2. This is precisely the misuse the metric's own inventor warned against. Eugene Garfield, who created the Journal Impact Factor, said in 2005: "I expected it to be used constructively while recognizing that in the wrong hands it might be abused," and separately warned that impact-factor-style metrics are "an inappropriate and misleading measure of individual research, especially if used for tenure and promotion." — source_tier: 4 (Wikipedia's impact-factor article; the direct quotes trace to Garfield's own 2005 conference remarks, a definitional/biographical claim about settled reception history, acceptable at this tier per sources.md, but a primary Garfield-text citation would strengthen it).

Why this was hop-worthy

The full arc closes a loop: a tool built to trace scholarly influence (1955) became a business (ISI -> Thomson -> private-equity-owned Clarivate, 2016) that sells a specific numeric credential, which a state actor then bought directly rather than earned — while the tool's own inventor had already named this exact failure mode decades earlier.

Further leads

• Clarivate's ownership itself (Onex Corporation + Baring Private Equity Asia, now NYSE: CLVT) — the "who profits from ranking science" angle wasn't pursued past the corporate-history level; worth a dedicated capture on PE-owned research infrastructure.
• Elsevier's Scopus as the rival commercial index (est. 2004) — not explored; a Clarivate-vs-Elsevier "duopoly politics" thread is available.
• The sibling captures 2026-07-09-hop-coercive-citation-dora and 2026-07-09-hop-hirsch-h-index-dias-superconductor-fraud cover the same seed's Shepard's Citations / Goodhart's Law / h-index branches — this capture deliberately takes the commercial-industry/nation-state-gaming branch to avoid overlap.

Hop chain

Hop 1: "The History of ISI and the work of Eugene Garfield" (Clarivate) / "Clarivate" — Wikipedia — https://clarivate.com/academia-government/the-institute-for-scientific-information/history/ ; https://en.wikipedia.org/wiki/Clarivate

• Hook type: The person behind the thing / cross-domain bridge (academia + private equity)
• Hook: ISI, Garfield's own company, was acquired by Thomson (1992), became Thomson Reuters IP & Science, then was sold in 2016 to private-equity firms Onex Corp and Baring Private Equity Asia and rebranded Clarivate.
• Why followed: Direct answer to the seed's redirect toward the commercial industry — the ownership chain is the "politics" layer.
• Key findings: A scholarly-infrastructure company that started as one man's index now sits inside a public, PE-originated holding company (NYSE: CLVT) alongside EndNote and Journal Citation Reports.

Hop 2: "Web of Science de-listed 82 journals" coverage (Chemistry World, Retraction Watch, Science/AAAS) — https://www.chemistryworld.com/news/how-clarivate-is-clamping-down-on-bad-actors-in-academic-publishing/4021494.article

• Hook type: Mechanism question
• Hook: Clarivate delisted 82 journals from Web of Science in March 2023 (after reviewing 500+) for citation cartels, paper mills, and inappropriate self-citation, affecting Hindawi, Taylor & Francis, and others.
• Why followed: Concrete mechanism of how a commercial gatekeeper polices (and profits from) scientific legitimacy today.
• Key findings: Nearly 20 Hindawi journals delisted specifically for paper-mill activity; the delisting criteria run to 24 quality checks.

Hop 3: "Saudi universities lose highly cited researchers after payment schemes raise ethics concerns" — Science/AAAS — https://www.science.org/content/article/saudi-universities-lose-highly-cited-researchers-after-payment-schemes-raise-ethics

• Hook type: Surprising claim / cross-domain bridge (bibliometrics + Gulf-state soft-power spending)
• Hook: KAU paid top-cited scientists real cash for a secondary affiliation, directly buying rank on Clarivate's flagship reputational product.
• Why followed: The most concrete, quantified instance of the industry's metric being purchased rather than earned — strongest "surprising claim" of the chain.
• Key findings: HCR-affiliated researcher count at KAU/KSU rose from 27 to 109 (2014-2022) then dropped to 76 after Clarivate's 2023 rule tightening on affiliation verification.

Hop 4: "Impact factor" — Wikipedia (summarizing Garfield's own statements) — https://en.wikipedia.org/wiki/Impact_factor

• Hook type: The person behind the thing (closing the loop on the seed's original figure)
• Hook: Garfield explicitly and repeatedly warned that his own metric shouldn't be used to judge individuals, anticipating the exact misuse found in Hop 3.
• Why followed: Zoom-out close: returns to the founder after three hops into the commercial/political mechanism, completing the alternation.
• Key findings: 2005 conference quote ("in the wrong hands it might be abused") plus a documented pattern of Garfield warnings against tenure/promotion use of impact-factor-style metrics.

Saved hooks not followed:

• Elsevier/Scopus as Clarivate's commercial rival — from Hop 1 — a genuine duopoly-politics thread, saved to avoid a 5th zoom-out hop diluting this chain's focus.
• Web of Science's paywalled access model (noted directly in the vault's own claim-linnainmaa-1976-citation-histogram as "Web of Science remains unpulled — no access") — from Hop 1 — a strong existing-note connection, saved because pursuing it would have meant re-opening an already-active vault thread rather than extending the hop.
• Private-equity ownership of research infrastructure as its own category (Clarivate is not unique) — from Hop 1 — worth a dedicated future capture.

post-worthy: maybe — well-sourced and closes a satisfying loop (inventor's warning -> industry's product -> state's purchase), but the individual facts (KAU scandal, Garfield's warnings) are each already fairly well-documented rather than newly surprising.